Pathstone Holdings’s Labcorp LH Stock Holding History

Pathstone Holdings’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.35M	Buy	12,557 +1,188	+10%	+$322K	0.01%	748
2025 Q4	$2.85M	Sell	11,369 -2,242	-16%	-$595K	0.01%	848
2025 Q3	$3.91M	Buy	13,611 +2,375	+21%	+$636K	0.01%	655
2025 Q2	$2.95M	Sell	11,236 -171	-1%	-$41.6K	0.01%	778
2025 Q1	$2.66M	Buy	11,407 +1,110	+11%	+$269K	0.01%	824
2024 Q4	$2.36M	Buy	10,297 +132	+1%	+$30.3K	0.01%	885
2024 Q3	$2.27M	Buy	10,165 +5,637	+124%	+$1.24M	0.01%	900
2024 Q2	$921K	Sell	4,528 -6,420	-59%	-$1.31M	﹤0.01%	1377
2024 Q1	$2.39M	Buy	10,948 +1,563	+17%	+$344K	0.01%	828
2023 Q4	$2.13M	Buy	+9,385	New	+$1.97M	0.01%	719

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pathstone Holdings's LH Position: Q1 2026 in Review

Pathstone Holdings increased its Labcorp (LH) stake by 10% in Q1 2026, buying an estimated $322K and bringing the position to 12,557 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #748.

Pathstone Holdings first reported a position in LH in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.91M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Pathstone Holdings held 12,557 shares of Labcorp worth $3.35M as of Q1 2026.
Pathstone Holdings bought 1,188 Labcorp shares in Q1 2026, an estimated $322K.
Labcorp made up 0.01% of Pathstone Holdings's portfolio in Q1 2026, its #748 holding.
Pathstone Holdings first reported a position in Labcorp in Q4 2023 and has held it in 10 quarters since.
Pathstone Holdings's Labcorp position peaked at $3.91M in Q3 2025.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.